• 1. Evolution study of photo-synthesized gold nanoparticles by spectral deconvolution model: a quantitative approach
  Chung-Sung Yang,Mong-Shian Shih,Fang-Yi Chang New J. Chem., 2006,30, 729-735
• 2. Estimation of activation energy for electroporation and pore growth rate in liquid crystalline and gel phases of lipid bilayers using molecular dynamics simulations?
  Amit Kumar Majhi,Subbarao Kanchi,V. Venkataraman,K. G. Ayappa,Prabal K. Maiti Soft Matter, 2015,11, 8632-8640
• 3. Excitable dynamics in the bromate–sulfite–ferrocyanide reaction
  J. Zagora,M. Vosla?,L. Schreiberová,I. Schreiber Phys. Chem. Chem. Phys., 2002,4, 1284-1291
• 4. Evolution in surface coverage of CH3NH3PbI3?XClXvia heat assisted solvent vapour treatment and their effects on photovoltaic performance of devices
  Dhirendra K. Chaudhary,Pramendra Kumar,Lokendra Kumar RSC Adv., 2016,6, 94731-94738
• 5. Excellent electrochemical performance of LiFe0.4Mn0.6PO4 microspheres produced using a double carbon coating process?
  Yong Ping Huang,Tao Tao,Zheng Chen,Wei Han,Ying Wu,Chunjiang Kuang,Shaoxiong Zhou,Ying Chen J. Mater. Chem. A, 2014,2, 18831-18837

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Indoles and derivatives Indolecarboxylic acids and derivatives

Introduction to 1-(2-methylpropyl)-1H-indole-3-carboxylic acid (CAS No. 739365-10-7)

1-(2-methylpropyl)-1H-indole-3-carboxylic acid, identified by its Chemical Abstracts Service number CAS No. 739365-10-7, is a significant compound in the realm of pharmaceutical and biochemical research. This molecule, featuring a substituted indole core, has garnered attention due to its structural uniqueness and potential biological activities. The indole scaffold is well-documented for its role in various pharmacological applications, making derivatives like this compound a subject of extensive interest among researchers.

The structural motif of 1-(2-methylpropyl)-1H-indole-3-carboxylic acid consists of a benzene ring fused to a pyrrole ring, with a carboxylic acid group at the 3-position and an isobutyl group at the 1-position. This specific arrangement imparts distinct chemical and pharmacological properties, which have been explored in recent studies. The presence of the carboxylic acid functionality allows for further derivatization, enabling the synthesis of more complex molecules with tailored biological activities.

In recent years, there has been a surge in research focusing on indole derivatives due to their diverse biological effects. Studies have highlighted the potential of indole-based compounds in modulating various cellular pathways, including those involved in inflammation, neurodegeneration, and cancer. Specifically, 1-(2-methylpropyl)-1H-indole-3-carboxylic acid has been investigated for its potential role in these areas. Preliminary findings suggest that this compound may exhibit inhibitory effects on certain enzymes and receptors, making it a promising candidate for further pharmacological development.

The synthesis of 1-(2-methylpropyl)-1H-indole-3-carboxylic acid involves multi-step organic reactions that require precise control over reaction conditions. Advanced synthetic methodologies have been employed to optimize yield and purity, ensuring that the final product meets the stringent standards required for pharmaceutical applications. Techniques such as palladium-catalyzed cross-coupling reactions and asymmetric synthesis have been particularly useful in constructing the complex framework of this molecule.

One of the most compelling aspects of 1-(2-methylpropyl)-1H-indole-3-carboxylic acid is its potential as a lead compound for drug discovery. The indole core is known to interact with a variety of biological targets, including transcription factors, cytokines, and enzymes. Researchers are exploring how modifications to this core structure can enhance binding affinity and selectivity, thereby improving therapeutic efficacy. The isobutyl group at the 1-position adds another layer of complexity, influencing both the physical properties and biological interactions of the molecule.

Recent computational studies have also shed light on the molecular dynamics of 1-(2-methylpropyl)-1H-indole-3-carboxylic acid. Molecular modeling techniques have been used to predict how this compound might bind to its target proteins, providing valuable insights into its mechanism of action. These studies often involve docking simulations, where virtual representations of the compound are tested against known binding sites on biological targets. Such simulations can help identify key interactions and guide the design of more effective derivatives.

The pharmacokinetic properties of 1-(2-methylpropyl)-1H-indole-3-carboxylic acid are another area of active investigation. Understanding how a compound is absorbed, distributed, metabolized, and excreted (ADME) is crucial for determining its potential as a drug candidate. Preliminary pharmacokinetic studies suggest that this compound may exhibit favorable properties in terms of solubility and bioavailability, although further experiments are needed to confirm these findings.

In conclusion,1-(2-methylpropyl)-1H-indole-3-carboxylic acid (CAS No. 739365-10-7) represents a promising avenue for pharmaceutical research due to its unique structural features and potential biological activities. The combination of synthetic chemistry advancements and computational modeling has accelerated the exploration of this compound's therapeutic potential. As research continues to unfold，it is likely that new applications for this molecule will emerge，contributing to advancements in medicine and biotechnology.

• 27018-76-4(1-benzyl-1H-indole-3-carboxylic acid)
• 141102-07-0(1-propyl-1H-indole-3-carboxylic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)